Both in Pharmaceuticals
Roivant Sciences vs Teva Pharmaceutical Industries Limited
Over the past year ROIV returned +88.3% and TEVA returned +105.1%; their daily moves had a correlation of 0.17.
ROIV +88.3% TEVA +105.1%Growth of $1, one year, split-adjusted
| Metric | ROIV | TEVA |
|---|---|---|
| Price | $36.91 | $42.09 |
| Market cap | $26.66B | $49.09B |
| Today | −1.63% | +1.50% |
| 1 month | +4.0% | +7.1% |
| 6 months | +32.6% | +20.4% |
| Year to date | +70.1% | +34.9% |
| 1 year | +96.7% | +108.1% |
| Revenue growth (YoY) | −33.5% | −0.8% |
| Gross margin | 100.0% | 52.0% |
| Net margin | −13164.8% | −13.9% |
| P/E (TTM) | — | 69.4× |
| Price / sales | 3,539.7× | 2.8× |
| Net cash | $3.84B | -$12.94B |
| Dividend yield | — | — |
| Volatility (60d) | 49.2% | 27.4% |
| Short % of float | 8.0% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).